METTL3 |
Acute myeloid leukemia |
Oncogene |
MYC↑, BCL2↑, PTEN↑ |
Inhibiting cell differentiation and apoptosis, increasing cell growth |
[244] |
Breast cancer |
Oncogene |
HBXIP↑ |
Promoting cell proliferation, inhibiting apoptosis |
[246, 277] |
Bladder cancer |
Oncogene |
miR-221/222↑, PTEN↓ |
Promoting cell growth |
[278] |
Oncogene |
SETD7↓, KLF4↓ |
Promoting cell proliferation and metastasis |
[279] |
Colorectal cancer |
Oncogene |
SOX2↓ |
Promoting tumorigenesis and cell metastasis |
[280] |
Tumor suppressor |
p-p38↓, p-ERK↓ |
Inhibiting cell proliferation, migration, and invasion |
[281] |
Glioblastoma |
Oncogene |
SRSFs↑ |
Promoting tumor growth and progression |
[282] |
Oncogene |
ADAR1↑ |
Promoting cancer progression |
[283] |
Lung cancer |
Oncogene |
JUNB↑ |
Increasing TGF-β-induced EMT |
[284] |
Oncogene |
BRD4↑ |
Promoting oncogenic transformation and tumor growth |
[285] |
Liver cancer |
Oncogene |
SOCS2↓ |
Promoting cell proliferation, migration, and colony formation |
[286] |
Oncogene |
RDM1↓ |
Increasing cell proliferation |
[287] |
METTL3, METTL14 |
Endometrial cancer |
Tumor suppressor |
PHLPP2↑, mTORC2↓ |
Inhibiting cell proliferation |
[288] |
Glioblastoma |
Tumor suppressor |
ADAM19↑, EPHA3↑, KLF4↑, CDKN2A↓, BRCA2↓, TP53I11↓ |
Suppressing tumor genesis, growth, and self-renewal |
[289] |
METTL14 |
Acute myeloid leukemia |
Oncogene |
MYC↑, MYB↑ |
Inhibiting cell differentiation, increasing cell proliferation |
[290] |
Breast cancer |
Oncogene |
DROSHA↑ |
Enhancing breast cancer stem-like cell stemness maintenance |
[291] |
Colorectal cancer |
Tumor suppressor |
SOX4↓ |
Inhibiting EMT |
[292] |
Tumor suppressor |
lncRNA XIST↓ |
Suppressing proliferation and metastasis |
[293] |
Pancreatic cancer |
Oncogene |
PERP↓ |
Promoting tumor growth and metastasis |
[294] |
WTAP |
Liver cancer |
Oncogene |
ETS1↓ |
Promoting cell proliferation and tumor growth |
[295] |
FTO |
Acute myeloid leukemia |
Oncogene |
MYC↑, CEBPA↑ |
Promoting cell proliferation and viability, inhibiting cell-cycle arrest and apoptosis |
[296] |
Oncogene |
ASB2↓, RARA↓ |
Enhancing cell transformation and leukemogenesis, inhibiting cell differentiation |
[297] |
Liver cancer |
Oncogene |
ALDOA↑ |
Promoting cell growth under hypoxia |
[298] |
Ovarian cancer |
Tumor suppressor |
PDE1C↓, PDE4B↓ |
Inhibiting the tumor self-renewal, suppressing tumorigenesis |
[299] |
ALKBH5 |
Acute myeloid leukemia |
Oncogene |
TACC3↑ |
Promoting tumor development and self-renewal |
[300] |
Lung cancer |
Tumor suppressor |
YAP↓ |
Inhibiting tumor growth and metastasis |
[301] |
Glioblastoma |
Oncogene |
FOXM1↑ |
Promoting cell proliferation |
[51] |
Pancreatic cancer |
Tumor suppressor |
PER1↑ |
Reducing cell proliferation, migration, and invasion, suppressing tumor growth |
[302] |
YTHDF1 |
Lung cancer |
Oncogene |
CDK2↑, CDK4↑, cyclind1↑, Keap1↑ |
Promoting cell proliferation and xenograft tumor formation |
[215] |
Liver cancer |
Oncogene |
EGFR↑ |
Promoting cell viability and metastasis |
[303] |
Ovarian cancer |
Oncogene |
EIF3C↑ |
Facilitating tumor genesis and metastasis |
[304] |
YTHDF2 |
Glioblastoma |
Oncogene |
MYC↑, VEGFA↑ |
Maintaining glioblastoma stem cell stemness |
[241] |
Liver cancer |
Tumor suppressor |
IL11↓, SERPINE2↓ |
Reducing tumor inflammation and causing vascular abnormalities |
[59] |
Prostate cancer |
Oncogene |
LHPP↓, NKX3-1↓ |
Inducing tumor proliferation and migration |
[305] |
YTHDF3 |
Breast cancer |
Oncogene |
ST6GALNAC5↑, GJA1↑, EGFR↑ |
Controlling the interaction of cancer and brain microenvironment, inducing brain metastasis |
[306] |
Colorectal cancer |
Oncogene |
LncRNA GAS5↓ |
Promoting cancer progression |
[307] |
IGF2BP1 |
Colorectal cancer |
Oncogene |
c-Myc↑ |
Promoting tumorigenesis |
[308] |
Ovarian, liver, and lung cancer |
Oncogene |
SRF↑, PDLIM7↑, FOXK1↑ |
Promote cell growth and invasion |
[309] |
IGF2BPs |
Cervical and liver cancer |
Oncogene |
MYC↑ |
Promoting tumorigenesis |
[310] |